Treatment Strategies of Adult Primary Focal Segmental Glomerulosclerosis: A Systematic Review Focusing on the Last Two Decades

Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis

(2015) Andreas Kronbichler et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group

(2015) Howard Trachtman et al.   BMC Nephrology

Rituximab Treatment for Relapsing Minimal Change Disease and Focal Segmental Glomerulosclerosis: A Systematic Review

(2014) Andreas Kronbichler et al.   AMERICAN JOURNAL OF NEPHROLOGY

Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome

(2014) P. Ruggenenti et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience

(2014) R. Ramachandran et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Treatment of Idiopathic FSGS with Adrenocorticotropic Hormone Gel

(2013) J. Hogan et al.   Clinical Journal of the American Society of Nephrology

Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial

(2013) Andrew Howman et al.   LANCET

Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases

(2013) Andreas Kronbichler et al.   WIENER KLINISCHE WOCHENSCHRIFT

Tacrolimus is an alternative therapy option for the treatment of adult steroid-resistant nephrotic syndrome: a prospective, multicenter clinical trial

(2012) Li Fan et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Treatment of Primary FSGS in Adults

(2012) S. M. Korbet   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Chapter 6: Idiopathic focal segmental glomerulosclerosis in adults

(2012)   Kidney International Supplements

Raised serum creatinine at presentation does not adversely affect steroid response in primary focal segmental glomerulosclerosis in adults

(2011) N. Jafry et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis

(2011) A. Fornoni et al.   Science Translational Medicine

Tacrolimus Therapy in Adults With Steroid- and Cyclophosphamide-Resistant Nephrotic Syndrome and Normal or Mildly Reduced GFR

(2009) Xiayu Li et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Rituximab Treatment of Adult Patients with Steroid-Resistant Focal Segmental Glomerulosclerosis

(2009) G. Fernandez-Fresnedo et al.   Clinical Journal of the American Society of Nephrology

Mycophenolate Mofetil in High-Risk Patients with Primary Glomerulonephritis: Results of a 1-Year Prospective Study

(2009) Nada Dimkovic et al.   NEPHRON CLINICAL PRACTICE

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A

(2008) Christian Faul et al.   NATURE MEDICINE

Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study

(2007) L. Senthil Nayagam et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION